Quo Vadis Point-of-Care Diagnostics? Report II of the SWISS SYMPOSIUM in Point-of-Care Diagnostics 2017

Biotechnet Switzerland

Authors

  • Marc E. Pfeifer Head of the Diagnostic Systems Research Group, Institute of Life Technologies, School of Engineering, Vice-Coordinator of the Health Technology Innovation Center (HTIC), HES-SO Valais-Wallis, Route du Rawil 47, Postfach 2134, CH-1950 Sitten 2, Switzerland. marc.pfeifer@hevs.ch

DOI:

https://doi.org/10.2533/chimia.2018.80

Keywords:

Analytical chemistry, Biomarker tracking, 'connected age', Cost of development, Systems approach

Abstract

U.S. studies show that the global point-of-care (POC) diagnostics market will reach $40.5 bn by 2022, with a compound annual growth rate (CAGR) of 10%. This is one of the reasons why HES-SO Valais-Wallis and CSEM, acting on behalf of the NTN Swiss Biotech thematic platform in vitro Diagnostics (TP IVD), invited interested parties on October 26, 2017 to the SWISS SYMPOSIUM in Point-of-Care Diagnostics (see CHIMIA No. 12/2017). We now bring the second report on the future prospects of POC diagnostics.
CHIMIA Vol. 72 No. 01-02(2018): Chemical Education

Downloads

Published

2018-02-01

Issue

Vol. 72 No. 1-2 (2018): Chemical Education

Section

Columns, Conference Reports

Categories

License

Copyright (c) 2018 Swiss Chemical Society

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite

[1]
Chimia 2018, 72, 80, DOI: 10.2533/chimia.2018.80.